Reuters logo
BRIEF-Divi's Laboratories USFDA completed evaluation of co's corrective actions in response to warning letter
November 10, 2017 / 3:42 AM / a month ago

BRIEF-Divi's Laboratories USFDA completed evaluation of co's corrective actions in response to warning letter

Nov 10 (Reuters) - Divi’s Laboratories Ltd

* Informed that USFDA completed evaluation of co’s corrective actions in response to FDA’s warning letter dated April 13 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below